Skip to main content

Table 2 DYRK2 immunohistochemical staining and clinical response (Fisher’s exact test: P = 0.0018)

From: Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy

DYRK2

Clinical response

Immunoreactive

CR

Non-CR

Positive

20

1

Negative

12

11

  1. CR complete response
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us